April 18, 2014 by Chain Drug Review
Issue 04-28-2014, News
SEATTLE — Brent Beebe has been appointed senior vice president of merchandising at Bartell Drugs, the oldest drug chain in th United States. He will develop and lead all aspects of merchandising and category management for the family-owned chain, as well as oversee merchandising innovation for the retailer’s 63 stores, which are located throughout King,
April 18, 2014 by Chain Drug Review
Issue 04-28-2014, News
CAMP HILL, Pa. — Rite Aid Corp. has appointed two retail veterans to its upper ranks. David Abelman was named to the newly created position of senior vice president of brand development and innovation, while Dedra Castle joined the drug chain as executive vice president and chief human resources officer. Abelman will oversee continued development
April 18, 2014 by Chain Drug Review
Issue 04-28-2014, News
WOONSOCKET, R.I. — Rob Price has stepped down as chief marketing officer at CVS/pharmacy. Price, who joined CVS in December 2006, has been at the center of the chain’s efforts to more closely integrate the store and digital environments to create a more personalized experience for shoppers and pharmacy patients, leveraging insights from the ExtraCare
April 18, 2014 by Chain Drug Review
Issue 04-28-2014, News
WASHINGTON — The enrollment of more than 7 million people in health insurance plans under the Affordable Care Act has led President Barack Obama to declare the law’s rollout a success. But Republican legislators vowed to continue to seek the statute’s repeal, and even though the ACA recorded its highest public approval level yet, at
April 18, 2014 by Chain Drug Review
Issue 04-28-2014, News
WALNUT CREEK, Calif. — Bob Long, who led Longs Drug Stores for more than 20 years, has died after a long illness. He was 75. Long was a well-known industry veteran who was honored in 2003 with Chain Drug Review’s Ronald L. Ziegler Lifetime Achievement Award. The award recognized his highly successful expansion strategies and
April 18, 2014 by Chain Drug Review
Issue 04-28-2014, Opinion
Bob Long died last month after a long illness that had depleted his energy and, in the end, his will to live. Finally, his body deserted him, shutting down and giving him the peace that had for so long eluded him. For a very long time, Long headed the drug chain that his father and
April 18, 2014 by Chain Drug Review
Issue 04-28-2014, Opinion
Whatever the ultimate fate of the Affordable Care Act, it is clear that fundamental changes in the way health care is delivered and paid for are taking place. Rite Aid understands that, and it has responded to two developments likely to endure even if Obamacare should falter — providers are increasingly being evaluated and remunerated
April 18, 2014 by Chain Drug Review
Issue 04-28-2014, Opinion
It’s time for the retail industry to wake up, open its wallet and ditch those loyalty cards. A little too strong? OK, then how about committing to some major out-of-the-box thinking on how to make these programs actually work — because it certainly is not happening now. For decades, loyalty cards have been pushed by
April 18, 2014 by Chain Drug Review
Issue 04-28-2014, Opinion
In a multipart series during 2014 our team will examine key product attributes and marketing tactics from two different perspectives — the consumer/shopper and the retail buyer. Our hope is that retail and wholesale buyers and product manufacturers will benefit from an objective picture of the viewpoints that contribute to a product’s success at retail.
April 18, 2014 by Chain Drug Review
Issue 04-28-2014, Opinion
The establishment of accountable care organizations (ACOs) under the Affordable Care Act is seen by many health policy professionals as one of the marquee components of the law. Certainly it is one of the few aspects of the ACA that has bipartisan political support and widespread enthusiasm among multiple stakeholders who are vested in the
April 18, 2014 by Chain Drug Review
Issue 04-28-2014, Opinion
The chain drug store industry is experiencing a major transformation driven by changes in how consumers interact with retailers and purchase products. Today’s newly empowered and connected consumers are increasingly turning to online stores and utilizing social and mobile technologies to access research, compare products and prices, and read reviews before making purchase decisions. They
April 18, 2014 by Bob O'Meara, Adam Pressman and Chain Drug Review
Issue 04-28-2014, Opinion
In today’s hyper-connected, cost-pressured, health-driven environment, there’s no shortage of ideas and issues impacting the health care value chain. Understanding which disruptors are true issues or opportunities and which ones are distractions is a critical element in developing a business strategy. Most of the discussions regarding health care today in the retail pharmacy sector have
April 4, 2014 by Chain Drug Review
Issue 04-07-2014, News
BUFFALO, N.Y. — Rite Aid Corp. has launched an innovative, first-of-its-kind health management initiative that links its stores to local doctors with the aim of providing comprehensive care to individuals with chronic health conditions. The Rite Aid Health Alliance is an integrated care model that seeks to help patients achieve health improvement goals established by
April 4, 2014 by Chain Drug Review
Issue 04-07-2014, News
WASHINGTON — A buildup of bipartisan opposition on Capitol Hill, along with negative reactions from patient groups, businesses, insurers and others, convinced the Centers for Medicare and Medicaid Services (CMS) not to proceed “at this time” with several controversial changes to the Medicare Part D prescription drug program. A CMS draft regulation that had been